Search Results - "Venhaus, R."

A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC) by O’Cearbhaill, R.E., Wolfer, A., Disilvestro, P., O’Malley, D.M., Sabbatini, P., Shohara, L., Schwarzenberger, P.O., Ricciardi, T., Macri, M., Ryan, A., Venhaus, R.R., Bryan, J.K., Wong, P., Homicsko, K., Kandalaft, L., Rusakiewicz, S., Harari, A., Monk, B.J., Coukos, G.

Get full text

Recombinant MAGE-A3 protein immunotherapy and peripheral blood lymphocyte (PBL) reconstitution induce strong antigen-specific humoral and cellular immune responses in patients undergoing autologous stem cell transplantation (ASCT) for consolidation of multiple myeloma (MM) by Lendvai, N, Cohen, A.D, Gnjatic, S, Jungbluth, A.A, Bertolini, S, Pan, L, Venhaus, R, Tsakos, I, Garcia, K, Thibodeau, L, Alpaugh, K, Cummings, N, Lehmann, F.F, Gruselle, O, Cho, H.J

Get full text

Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma by Carroll, Thomas M., Chadwick, Joseph A., Owen, Richard P., White, Michael J., Kaplinsky, Joseph, Peneva, Iliana, Frangou, Anna, Xie, Phil F., Chang, Jaeho, Roth, Andrew, Amess, Bob, James, Sabrina A., Rei, Margarida, Fuchs, Hannah S., McCann, Katy J., Omiyale, Ayo O., Jacobs, Brittany-Amber, Lord, Simon R., Norris-Bulpitt, Stewart, Dobbie, Sam T., Griffiths, Lucinda, Ramirez, Kristen Aufiero, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph R., Van den Eynde, Benoit J., Karydis, Ioannis, Schuster-Böckler, Benjamin, Middleton, Mark R., Lu, Xin, Ahern, David, Amess, Bob, Ramirez, Kristen Aufiero, Berridge, Georgina, Carroll, Thomas M., Chadwick, Joseph A., Chang, Jaeho, Cheng, Jingfei, Dobbie, Sam T., Drozdz, Magdalena, Fischer, Roman, Frangou, Anna, Fuchs, Hannah S., Griffiths, Lucinda, Inoue, Masato, Jacobs, Brittany-Amber, James, Sabrina A., Kaplinsky, Joseph, Karydis, Ioannis, Kessler, Benedikt M., Lord, Simon R., Lou, Hantao, Lu, Xin, Macri, Mary J., McCann, Katy J., McGregor, Naomi, Middleton, Mark R., Norris-Bulpitt, Stewart, Omiyale, Ayo O., Owen, Richard P., Peneva, Iliana, Phetsouphanh, Chansavath, Rei, Margarida, Ricciardi, Toni, Roth, Andrew, Puig, Carlos Ruiz, Ryan, Aileen, Schuster-Böckler, Benjamin, Siejka-Zielińska, Paulina, Song, Chunxiao, Tomkova, Marketa, Van den Eynde, Benoit J., Velikova, Gergana, Venhaus, Ralph R., White, Michael J., Xie, Phil F.

“…For inoperable esophageal adenocarcinoma (EAC), identifying patients likely to benefit from recently approved immunochemotherapy (ICI+CTX) treatments remains a…”
Get full text

Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer by Hall, Peter E., Ready, Neal, Johnston, Amanda, Bomalaski, John S., Venhaus, Ralph R., Sheaff, Michael, Krug, Lee, Szlosarek, Peter W.

“…Pre-clinical studies indicated that arginine-deprivation therapy using pegylated arginine deiminase (pegargiminase, ADI-PEG 20) may be effective in patients…”
Get full text

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant by Adams, Sylvia, O'Neill, David W, Nonaka, Daisuke, Hardin, Elizabeth, Chiriboga, Luis, Siu, Kimberly, Cruz, Crystal M, Angiulli, Angelica, Angiulli, Francesca, Ritter, Erika, Holman, Rose Marie, Shapiro, Richard L, Berman, Russell S, Berner, Natalie, Shao, Yongzhao, Manches, Olivier, Pan, Linda, Venhaus, Ralph R, Hoffman, Eric W, Jungbluth, Achim, Gnjatic, Sacha, Old, Lloyd, Pavlick, Anna C, Bhardwaj, Nina

“…T cell-mediated immunity to microbes and to cancer can be enhanced by the activation of dendritic cells (DCs) via TLRs. In this study, we evaluated the safety…”
Get full text

NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus by Chen, Ji‐Li, Dawoodji, Amina, Tarlton, Andrea, Gnjatic, Sacha, Tajar, Abdelouahid, Karydis, Ioannis, Browning, Judy, Pratap, Sarah, Verfaille, Christian, Venhaus, Ralph R., Pan, Linda, Altman, Douglas G., Cebon, Jonathan S., Old, Lloyd L., Nathan, Paul, Ottensmeier, Christian, Middleton, Mark, Cerundolo, Vincenzo

“…Vaccination strategies based on repeated injections of NY‐ESO‐1 protein formulated in ISCOMATRIX particles (NY‐ESO‐1 ISCOMATRIX) have shown to elicit combined…”
Get full text

A Phase 1 Clinical Trial of Ipilimumab, Nivolumab and Radiation Therapy for Patients with Metastatic Melanoma by Barker, C.A., Postow, M.A., Goldman, D.A., Panageas, K.S., Halpenny, D., McCabe, D., Macri, M., Schwarzenberger, P., Ricciardi, T., Ryan, A., Venhaus, R., Knox, S.J.

Get full text

945PA phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC) by O'Cearbhaill, R E, Wolfer, A, Disilvestro, P, O'Malley, D M, Sabbatini, P, Shohara, L, Schwarzenberger, P O, Ricciardi, T, Macri, M, Ryan, A, Venhaus, R R, Bryan, J K, Wong, P, Homicsko, K, Kandalaft, L, Rusakiewicz, S, Harari, A, Monk, B J, Coukos, G

Get full text

Advanced rehabilitation nursing care of coronary angioplasty patients using self-efficacy theory by Jensen, K, Banwart, L, Venhaus, R, Popkess-Vawter, S, Perkins, S B

“…The rapidly increasing numbers of patients who experience coronary angioplasty have not been widely studied concerning their rehabilitation, risk factor…”
Get more information

Phase I/II study of arginine deiminase (ADI-PEG 20) in patients with advanced malignant melanoma (MM) by Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E., Venhaus, R., Pan, L., Old, L., Pavlick, A. C., Wolchok, J. D.

“…Abstract only 9030 Background: ADI-PEG 20 is an enzyme that degrades arginine, a crucial amino acid central to metabolism and biosynthesis of growth and…”
Get full text

Phase I trial of huA33 antibody plus 5-fluorouracil (5FU), leucovorin, and oxaliplatin in patients with metastatic colorectal cancer [LUD2003–005] by Renner, C., Ritter, G., Pan, L., Venkatramin, E., Hoffman, E. W., Venhaus, R., Old, L., Knuth, A., Jäger, E., Pfreundschuh, M.

“…Abstract only 3022 Background: The selective targeting of tumors with monoclonal antibodies (mAb) has emerged as a new therapeutic approach in cancer therapy…”
Get full text

Abstract 1247: Comprehensive molecular profiling to predict first-line immunochemotherapy outcomes in inoperable esophageal adenocarcinoma by Carroll, Thomas M., Chadwick, Joseph A., Owen, Richard P., White, Michael J., Kaplinsky, Joseph, Peneva, Iliana, Frangou, Anna, Chang, Jaeho, Xie, Phil F., Roth, Andrew, Amess, Bob, Lou, Hantao, McCann, Katy J., Berridge, Georgina, Fischer, Roman, Phetsouphanh, Chansavath, Omiyale, Ayo O., Jacobs, Brittany-Amber, Ahern, David, Lord, Simon R., Norris-Bulpitt, Stewart, Dobbie, Sam T., Griffiths, Lucinda, Ramirez, Kristen Aufiero, Ricciardi, Toni, Macri, Mary J., Ryan, Aileen, Venhaus, Ralph R., Van den Eynde, Benoit J., Karydis, Ioannis, Kessler, Benedikt M., Schuster-Böckler, Benjamin, Middleton, Mark R., Lu, Xin

“…Abstract For patients with inoperable esophageal adenocarcinoma (EAC), prognosis on conventional chemotherapy (CTX) remains poor. In 2021, the FDA approved two…”
Get full text

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using Toll-like receptor 7 agonist imiquimod as vaccine adjuvant by Adams, Sylvia, O'Neill, David W., Nonaka, Daisuke, Hardin, Elizabeth, Chiriboga, Luis, Siu, Kimberly, Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Ritter, Erika, Holman, Rose Marie, Shapiro, Richard L., Berman, Russell S., Berner, Natalie, Shao, Yongzhao, Manches, Olivier, Pan, Linda, Venhaus, Ralph R., Hoffman, Eric W., Jungbluth, Achim, Gnjatic, Sacha, Old, Lloyd, Pavlick, Anna C., Bhardwaj, Nina

“…T cell-mediated immunity to microbes and to cancer can be enhanced by the activation of dendritic cells (DCs) via Toll-like receptors (TLRs). In this study, we…”
Get full text